Advisor Group’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $65K | Sell |
1,395
-196
| -12% | -$9.13K | ﹤0.01% | 3232 |
|
|
2019
Q3 | $60K | Sell |
1,591
-314
| -16% | -$11.8K | ﹤0.01% | 3247 |
|
|
2019
Q2 | $83K | Sell |
1,905
-296
| -13% | -$12.9K | ﹤0.01% | 2994 |
|
|
2019
Q1 | $83K | Sell |
2,201
-248
| -10% | -$9.35K | ﹤0.01% | 3013 |
|
|
2018
Q4 | $104K | Buy |
2,449
+223
| +10% | +$9.47K | ﹤0.01% | 2622 |
|
|
2018
Q3 | $109K | Buy |
2,226
+463
| +26% | +$22.7K | ﹤0.01% | 2697 |
|
|
2018
Q2 | $57K | Buy |
1,763
+21
| +1% | +$679 | ﹤0.01% | 2972 |
|
|
2018
Q1 | $55K | Buy |
1,742
+54
| +3% | +$1.71K | ﹤0.01% | 2986 |
|
|
2017
Q4 | $77K | Sell |
1,688
-186
| -10% | -$8.49K | ﹤0.01% | 2767 |
|
|
2017
Q3 | $70K | Buy |
1,874
+42
| +2% | +$1.57K | ﹤0.01% | 2687 |
|
|
2017
Q2 | $88K | Buy |
1,832
+389
| +27% | +$18.7K | ﹤0.01% | 2413 |
|
|
2017
Q1 | $67K | Buy |
1,443
+70
| +5% | +$3.25K | ﹤0.01% | 2479 |
|
|
2016
Q4 | $44K | Sell |
1,373
-557
| -29% | -$17.9K | ﹤0.01% | 2710 |
|
|
2016
Q3 | $66K | Buy |
1,930
+233
| +14% | +$7.97K | ﹤0.01% | 2302 |
|
|
2016
Q2 | $55K | Buy |
+1,697
| New | +$55K | ﹤0.01% | 2354 |
|